DUBLIN--(BUSINESS WIRE)--The "Global Prostate Cancer Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to Research and Markets' offering.
The prostate cancer treatment market was valued at US$5.63 Bn in 2016, and is expected to reach US$ 18.4 Bn by 2025 expanding at a CAGR of 12.3% from 2017 to 2025.
The key risk factors for prostate cancer development is being old age, genetic, obesity and race. Around 99% of the cases for prostate cancer is most commonly seen after the age of 50 years. The currently available treatment are biological therapy and chemotherapy. Biological therapy are considered as the largest segment of prostate cancer treatment market as it is the preferred first line of treatment. Chemotherapy is an option to the patients who are resistant to the Biological therapy. The key factors assisting the growth of prostate cancer treatment market are growing prevalence of prostate cancer coupled with growing public awareness, rising healthcare expenditure in the developed and developing regions and developing technology of pharmaceutical companies leading to more target specific drugs with lesser side effects and strong emerging pipeline. On the other hand, insufficient funding in developing and under developed countries and high cost involved in the treatment of the disease are hindering the market growth of prostate cancer treatment.
Key Market Movements:
- Rising prevalence of prostate cancer in developed and developing countries
- Aging population, in developed countries is expected to boost the market
- Government and non-government initiatives to fight prostate cancer and supporting reimbursement policies
- Rising public awareness with early disease diagnosis and strong emerging pipeline is expected to boost the Prostate cancer treatment market
Key Topics Covered:
Chapter 1 Preface
Chapter 2 Executive Summary
Chapter 3 Prostate Cancer Treatment Market Analysis
Chapter 4 Global Prostate Cancer Treatment Market Analysis, by Treatment
Chapter 5 Global Prostate Cancer Treatment Market, By Geography
Chapter 6 Company Profiles
- Tolmar Inc.
- Astellas Pharma, Inc.
- AstraZeneca Plc
- Ferring Pharmaceuticals
- Johnson & Johnson
- Abbott Laboratories
- Bayer Healthcare Pharmaceuticals, Inc
For more information about this report visit https://www.researchandmarkets.com/research/wxtf93/global_prostate